OA
MRK icon

Oxbow Advisors’s Merck MRK Stock Holding History

Oxbow Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Hold
3,283
– – 0.03% 187
2025
Q4 		$346K Buy
3,283
+400
+14% +$37.5K 0.03% 199
2025
Q3 		$242K Buy
+2,883
New +$237K 0.02% 205
2024
Q4 		– Sell
-49,278
Closed -$5.6M – 226
2024
Q3 		$5.6M Buy
49,278
+25,836
+110% +$3.07M 0.56% 48
2024
Q2 		$2.9M Buy
23,442
+18,710
+395% +$2.41M 0.34% 59
2024
Q1 		$624K Sell
4,732
-2,962
-38% -$365K 0.09% 111
2023
Q4 		$839K Buy
7,694
+17
+0.2% +$1.76K 0.13% 93
2023
Q3 		$790K Sell
7,677
-4,651
-38% -$501K 0.12% 88
2023
Q2 		$1.42M Buy
12,328
+2,225
+22% +$253K 0.22% 65
2023
Q1 		$1.07M Sell
10,103
-1,036
-9% -$112K 0.19% 74
2022
Q4 		$1.24M Buy
11,139
+1,419
+15% +$145K 0.23% 72
2022
Q3 		$837K Sell
9,720
-282
-3% -$25.2K 0.13% 112
2022
Q2 		$912K Buy
10,002
+5,737
+135% +$509K 0.13% 111
2022
Q1 		$350K Sell
4,265
-119,887
-97% -$9.45M 0.04% 208
2021
Q4 		$9.52M Sell
124,152
-1,146
-0.9% -$91.3K 0.91% 43
2021
Q3 		$9.41M Buy
125,298
+1,010
+0.8% +$76.8K 0.96% 37
2021
Q2 		$9.67M Sell
124,288
-1,110
-0.9% -$82.6K 1% 34
2021
Q1 		$9.22M Buy
125,398
+855
+0.7% +$63.1K 1.12% 30
2020
Q4 		$9.72M Sell
124,543
-2,031
-2% -$155K 1.24% 26
2020
Q3 		$10M Buy
126,574
+61,008
+93% +$4.78M 1.27% 19
2020
Q2 		$4.84M Buy
65,566
+59,472
+976% +$4.48M 0.7% 47
2020
Q1 		$447K Sell
6,094
-1,196
-16% -$94K 0.08% 183
2019
Q4 		$633K Buy
7,290
+859
+13% +$70.6K 0.07% 189
2019
Q3 		$517K Buy
6,431
+113
+2% +$9.06K 0.07% 192
2019
Q2 		$506K Sell
6,318
-2,516
-28% -$193K 0.06% 207
2019
Q1 		$701K Hold
8,834
– – 0.09% 179
2018
Q4 		$644K Sell
8,834
-324
-4% -$22.9K 0.09% 173
2018
Q3 		$620K Sell
9,158
-2,013
-18% -$128K 0.07% 187
2018
Q2 		$647K Hold
11,171
– – 0.08% 176
2018
Q1 		$581K Sell
11,171
-369
-3% -$19.9K 0.12% 141
2017
Q4 		$620K Sell
11,540
-418
-3% -$23.2K 0.12% 152
2017
Q3 		$731K Sell
11,958
-89
-0.7% -$5.4K 0.14% 141
2017
Q2 		$737K Hold
12,047
– – 0.13% 146
2017
Q1 		$730K Buy
12,047
+1,908
+19% +$116K 0.12% 148
2016
Q4 		$570K Hold
10,139
– – 0.07% 167
2016
Q3 		$604K Sell
10,139
-215
-2% -$12.6K 0.08% 155
2016
Q2 		$569K Sell
10,354
-315
-3% -$16.8K 0.08% 157
2016
Q1 		$539K Sell
10,669
-80,428
-88% -$3.94M 0.08% 162
2015
Q4 		$4.59M Buy
91,097
+17,881
+24% +$902K 0.57% 52
2015
Q3 		$3.45M Sell
73,216
-41,424
-36% -$2.2M 0.57% 52
2015
Q2 		$6.23M Sell
114,640
-5,513
-5% -$309K 0.8% 30
2015
Q1 		$6.59M Buy
120,153
+6,191
+5% +$351K 0.98% 29
2014
Q4 		$6.17M Buy
113,962
+528
+0.5% +$29.4K 0.86% 37
2014
Q3 		$6.42M Sell
113,434
-1,654
-1% -$92.9K 0.91% 38
2014
Q2 		$6.35M Buy
115,088
+1,015
+0.9% +$55.4K 0.84% 40
2014
Q1 		$6.18M Sell
114,073
-1,425
-1% -$73.8K 0.92% 39
2013
Q4 		$5.52M Buy
115,498
+13,065
+13% +$597K 0.78% 46
2013
Q3 		$4.65M Sell
102,433
-1,238
-1% -$56.5K 0.74% 44
2013
Q2 		$4.59M Buy
+103,671
New +$4.63M 0.81% 32

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oxbow Advisors's MRK Position: Q1 2026 in Review

Oxbow Advisors held its Merck (MRK) position steady in Q1 2026 at 3,283 shares worth $395K. The position accounts for 0.03% of the portfolio, ranked #187.

Oxbow Advisors first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. The position peaked at $10M in Q3 2020. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Oxbow Advisors held 3,283 shares of Merck worth $395K as of Q1 2026.
  • Oxbow Advisors left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.03% of Oxbow Advisors's portfolio in Q1 2026, its #187 holding.
  • Oxbow Advisors first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
  • Oxbow Advisors's Merck position peaked at $10M in Q3 2020.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Oxbow Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.